Axs Investments LLC Cardiol Therapeutics Inc. Transaction History

Axs Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$0.67 - $1.0 $50,842 - $75,884	-75,884 Reduced 9.81%	697,651 $586,000
Q3 2023 Nov 09, 2023	SELL	$0.76 - $1.19 $399,411 - $625,393	-525,541 Reduced 40.45%	773,535 $696,000
Q2 2023 Aug 10, 2023	SELL	$0.45 - $0.97 $192,937 - $415,888	-428,751 Reduced 24.81%	1,299,076 $1.16 Million
Q1 2023 May 12, 2023	BUY	$0.47 - $0.81 $812,078 - $1.4 Million	1,727,827 New	1,727,827 $846,000

5.07M

5.2K

9.5K

Ticker CRDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 61,942,500
Market Cap $98.5M
Description
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...

Get notified when there are updates to the investment portfolio of Axs Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Axs Investments LLC with notifications on news.